The 3rd European Hematology and Blood Disorders Congress, slated for September 14-15, 2026, in London, UK, promises to be a cornerstone event in the field of hematology. Bringing together leading researchers, clinicians, and industry professionals, this congress will showcase the latest advancements and discoveries in hematology and blood disorders.
Participants can expect a comprehensive program covering a wide spectrum of topics, including hematologic malignancies like leukemia, lymphoma, and myeloma, as well as non-malignant disorders such as anemia, hemophilia, and thrombosis. Key sessions will highlight breakthrough therapies such as cell therapy, gene editing technologies, and novel drug developments, aiming to enhance treatment outcomes and patient care.
Beyond scientific presentations, the congress will facilitate networking opportunities and collaborative discussions, fostering partnerships among experts from diverse backgrounds. Rome, renowned for its historical landmarks and cultural richness, will provide an inspiring backdrop for this intellectual exchange.